首 页 关于中昊 新闻资讯 产品目录 资料下载 订购须知 人才招聘 代理品牌 联系我们
详细查找
 
Lyophilized Factor XII Inhibitor Plasma – 1ml
INH12-LDP Affinity
待定 / 1ml
推荐产品
热门产品
产品说明 / Product Overview:

Factor XII Inhibitor Plasma
Factor XII Inhibitor Plasma is manufactured from normal citrated human plasma depleted of Factor XII using antibodies directed to FXII immobilized on agarose beads.  A polyclonal antibody inhibitory to FXII has been added to provide FXII neutralizing activity.  The neutralizing antibody activity is determined by Nijmegen-modified Bethesda Inhibitor Assay and has values reported in Bethesda Units.  Our Factor XII Inhibitor Plasma is produced with a mild inhibitor titre or neutralizing activity ranging from 1 BU/ml to 10 BU/ml and is available in two different formats – Frozen and Lyophilized

Only the highest quality citrated plasma is used as starting material and in many cases the parent plasma is available as control material.  Our Factor XII Inhibitor Plasma can be used for further manufacturing or research use only applications.

Description of Factor XII (FXII)
Factor XII (FXII, Hageman factor) is a 76 kDa, single chain glycoprotein produced in the liver. In plasma, FXII circulates as a protease zymogen at a concentration of approximately 30 μg/ml (400 nM). Upon vascular injury FXII binds to negatively charged extravascular surfaces such as cartilage and skin, which facilitate activation of the zymogen to the active serine protease. Cleavage of F.XII by kallikrein after residue Arg353 produces the enzyme αFXIIa, consisting of a 28 kDa light chain containing the protease domain, and a 52 kDa heavy chain containing the anionic surface-binding domain. Substrates for surface bound FXIIa include the zymogens prekallikrein (PK) and factor XI (FXI) as well as the procofactor high-molecular weight kininogen (HK). The activation of these substrates results in positive feedback activation of FXII. Further cleavage of αFXIIa by kallikrein produces the 28 kDa fragment βFXIIa (Hageman factor fragment). βFXIIa has reduced procoagulant activity as it lacks the anionic surface-binding domain, but is capable of fluid-phase activation of PK, factor VII and complement C1. The activity of F.XIIa in plasma is regulated predominantly by C1-Inhibitor, with relatively minor contributions by α2antiplasmin, α2macroglobulin and antithrombin, even in the presence of therapeutic levels of heparin1-3.

说明书

相关产品 / Related Products :
  • 山羊抗人因子XII纯化IgG / Goat anti-human Factor XII (F.XII) Whole IgG from antis
  • 人因子XII抗原Elisa匹配抗体Matched-Pair Antibody Set for ELISA of human Factor XI
  • 绵羊抗人因子XII亲和纯化IgG / Sheep anti-human Factor XII (F.XII) Affinity Purifi
  • 绵羊抗人因子XII纯化IgG / Sheep anti-human Factor XII (F.XII) Whole IgG from anti
  • 山羊抗人因子XII过氧化物酶标记IgG / Goat anti-human Factor XII (F.XII) Peroxidase
  • 山羊抗人因子XII亲和纯化IgG / Goat anti-human Factor XII (F.XII) Affinity Purifie
  • Anti Human Factor XII, Clone 11B9
  • Anti Human Factor XII, Clone 20B2
  •  
    版权所有:北京中昊新生科技有限责任公司 | 电话:010-59871930 59871931 统一服务热线:400-888-0207
    传真:010-59871932 邮箱:info@biopcr.com
    Copyright © 2009-2017 biopcr.com. All Rights Reserved. 京ICP备17062316号 京公网安备11010802024962号